ReviewHuman vaccines & immunotherapeutics2023
Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review.
Nikolaos Giannelos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it